A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder

NCT00518232 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

520

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: OROS-methylphenidate

Sponsor

Johnson & Johnson Taiwan Ltd